Interventional Cardiology Service
The Cardiac Catheterization Laboratories of Beth Israel Deaconess Medical Center are among the busiest in the world, performing more than 4,000 procedures annually. In addition, more than 30 percent of interventional patients are currently enrolled in research studies for the evaluation of new stents and other technologies. Dr. Donald Cutlip, Chief of the Interventional Cardiology Section, coordinates the operation of the laboratories, which include five all-digital laboratories as well as two electrophysiology facilities.
Training in Cardiac Catheterization. Between the first and second years of fellowship training, cardiac fellows generally spend five months in the Cardiac Catheterization Laboratory. Emphasizing their pivotal role, a first or second year fellow is scrubbed in on all catheterization cases including emergency and "off-hour" cases. Each fellow performs between 300 and 400 procedures during that time, under the direct supervision of a senior staff attending.
The fellow is responsible for pre- and post-procedure evaluation of the patient, and for preparation of the catheterization report. Fellows also participate in specialized procedures such as intra-aortic balloon pump placement, pericardiocentesis, ethanol septal ablation, percutaneous PFO/ASD closure and hemodynamic assessment with inhaled nitric oxide for patients with pulmonary hypertension and/or congenital heart disease. For those interested in advanced training in Interventional Cardiology, participation in research projects during the second year of fellowship is encouraged. A select group of fellows (chosen at the end of their second fellowship year for invasive skills and research potential) will have the opportunity to acquire advanced training in interventional cardiology during a third and fourth year of study.
Training in Interventional Cardiology. The Interventional Cardiology Fellowship is an ACGME-certified program for comprehensive training in all aspects of interventional cardiology. It provides fellows with early exposure to "leading edge" technologies including coated stents, distal protection devices, brachytherapy, directed angiogenesis and catheters for induction of controlled hypothermia during reperfusion for acute myocardial infarction. The evaluation of these devices also introduces fellows to the principles and practices of clinical trials. The fellowship is an intensive two-year combined clinical and research program. At its completion, each fellow will have performed approximately 800 interventional procedures, and will be eligible to take the certification examination in Interventional Cardiology given by the American Board of Internal Medicine.
Recognizing the strong association between coronary and peripheral arterial disease, comprehensive training in the evaluation and management of patients with peripheral vascular disease is also a key part of the program.